Leslie Chong is the CEO and Managing Director of Imugene, an ASX-listed biotechnology company. Based in Sydney, Australia.
Dr. Leslie Chong is the CEO and Managing Director of Imugene, an ASX-listed biotechnology company. She initially funded the company and then led it through a backdoor listing, establishing a market cap of around $6 million. Chong has positioned Imugene to advance its clinical trials and R&D initiatives.
Full founder directory · Investor directory · Company funding database · Fundraising library